Aclaris Therapeutics, Inc. Shares Outstanding (Cover Page)
Aclaris Therapeutics, Inc. (ACRS) had Shares Outstanding (Cover Page) of 147.20 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 147.20M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 139.66M shares.
- 2026-01-30: Entity Common Stock, Shares Outstanding 120.60M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 108.35M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 147.20M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 139.66M shares 10-Q · filed 2026-05-07 |
| 2026-01-30 | 120.60M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 108.35M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 108.33M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 108.28M shares 10-Q · filed 2025-05-08 |
| 2025-01-31 | 107.92M shares 10-K · filed 2025-02-27 |
| 2024-10-31 | 71.43M shares 10-Q · filed 2024-11-06 |
| 2024-07-31 | 71.34M shares 10-Q · filed 2024-08-07 |
| 2024-04-30 | 71.26M shares 10-Q · filed 2024-05-07 |
| 2024-01-31 | 70.93M shares 10-K · filed 2024-02-27 |
| 2023-10-31 | 70.84M shares 10-Q · filed 2023-11-06 |
| 2023-07-31 | 70.79M shares 10-Q · filed 2023-08-07 |
| 2023-04-28 | 70.68M shares 10-Q · filed 2023-05-08 |
| 2023-01-31 | 66.69M shares 10-K · filed 2023-02-23 |
| 2022-10-31 | 66.68M shares 10-Q · filed 2022-11-08 |
| 2022-07-29 | 66.67M shares 10-Q · filed 2022-08-03 |
| 2022-04-29 | 66.58M shares 10-Q · filed 2022-05-10 |
| 2022-01-31 | 61.28M shares 10-K · filed 2022-02-24 |
| 2021-10-29 | 61.23M shares 10-Q · filed 2021-11-02 |
| 2021-07-30 | 61.22M shares 10-Q · filed 2021-08-05 |
| 2021-04-30 | 52.11M shares 10-Q · filed 2021-05-07 |
| 2021-01-31 | 51.80M shares 10-K · filed 2021-02-25 |
| 2020-10-31 | 42.92M shares 10-Q · filed 2020-11-04 |
| 2020-08-06 | 42.72M shares 10-Q · filed 2020-08-07 |
| 2020-05-01 | 41.87M shares 10-Q · filed 2020-05-07 |
| 2020-02-24 | 41.53M shares 10-K · filed 2020-02-25 |
| 2019-11-07 | 41.39M shares 10-Q · filed 2019-11-07 |
| 2019-08-05 | 41.37M shares 10-Q · filed 2019-08-08 |
| 2019-05-07 | 41.27M shares 10-Q · filed 2019-05-08 |
| 2019-03-15 | 41.27M shares 10-K · filed 2019-03-18 |
| 2018-11-05 | 40.94M shares 10-Q · filed 2018-11-06 |
| 2018-08-02 | 30.98M shares 10-Q · filed 2018-08-03 |
| 2018-05-07 | 30.91M shares 10-Q · filed 2018-05-08 |
| 2018-03-09 | 30.90M shares 10-K · filed 2018-03-12 |
| 2017-11-06 | 30.83M shares 10-Q · filed 2017-11-07 |
| 2017-08-07 | 26.74M shares 10-Q · filed 2017-08-08 |
| 2017-05-08 | 26.73M shares 10-Q · filed 2017-05-09 |
| 2017-03-14 | 26.09M shares 10-K · filed 2017-03-15 |
| 2016-11-02 | 21.43M shares 10-Q · filed 2016-11-03 |
| 2016-08-10 | 21.42M shares 10-Q · filed 2016-08-11 |
| 2016-05-11 | 20.32M shares 10-Q · filed 2016-05-11 |
| 2016-03-23 | 20.16M shares 10-K · filed 2016-03-23 |
| 2015-11-17 | 20.16M shares 10-Q · filed 2015-12-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |